CASI Pharmaceuticals, Inc. (CASI)
0.8435
-0.01
(-1.56%)
USD |
NASDAQ |
Dec 10, 16:00
0.8335
-0.01
(-1.19%)
After-Hours: 20:00
CASI Pharmaceuticals Total Liabilities (Quarterly): 53.05M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | 7.491M |
| Zai Lab Ltd. | 398.99M |
| Adagene, Inc. | -- |
| Adlai Nortye Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.33M |
| Shareholders Equity (Quarterly) | -25.73M |
| Debt to Equity Ratio | -0.7329 |
| Current Ratio | 0.3023 |
| Net Debt Paydown Yield | -0.23% |